Rapid Nutrition Sets its Sights on the Flourishing Chinese Consumer Market
London, United Kingdom – 18 July 2023 - Rapid Nutrition PLC (Euronext Growth: ALRPD), a globally renowned health and wellness company, is delighted to reaffirm its commitment to unlocking growth opportunities by announcing its strategic entry into the rapidly expanding Chinese consumer market. This strategic decision, as disclosed on the 11th of June, marks a significant turning point in the company's trajectory, with the aim of positioning Rapid Nutrition as a frontrunner in the ever-thriving Chinese marketplace.
Rapid Nutrition's decision to venture into the Chinese market is driven by market trends and deep analysis in order to capitalise and expand its horizons and cater to an even broader international audience. With China's dynamic and burgeoning health and wellness sector, the company is poised to tap into a vast consumer base that demands innovative and high-quality nutritional products.
Our unwavering focus on evidence-backed formulations, premium quality, and customer-centric approach aligns seamlessly with the evolving preferences of the discerning Chinese consumer.
"China presents a remarkable opportunity for Rapid Nutrition to create a profound impact, and we are thrilled to embrace this new chapter in our journey," says Simon St Ledger, the CEO of Rapid Nutrition. "As a responsible global health and wellness brand, we are fully committed to offering Chinese consumers the finest nutritional products that cater to their unique needs."
In light of this exciting milestone, Rapid Nutrition is pleased to present a comprehensive presentation that delves into the intricacies of our foray into the Chinese consumer market. This presentation aims to offer valuable insights, intricate details, and a strategic outlook on how we intend to navigate this promising venture.
"This presentation is designed to provide our shareholders with an in-depth understanding of our approach to the Chinese market," states Simon St Ledger.
The presentation can be accessed through the following link: https://www.rnplc.com/investors/presentations/ . Rapid Nutrition encourages all shareholders, investors, and stakeholders to review the presentation to gain valuable insights into the company's strategic direction, growth plans, and projected outcomes in the Chinese consumer market.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).